In a subset of patients attending liver units, a chronic increase in serum
transaminases may remain of undetermined cause despite thorough investigati
ons. On the other hand, elevated levels of serum transaminases have been re
ported in about 40% of adult celiac patients. To evaluate the prevalence of
subclinical celiac disease in patients with chronic unexplained hypertrans
aminasemia in comparison with that in the general population (0.5%), 140 co
nsecutive patients with chronic increases of serum transaminases levels of
unknown cause were tested for antigliadin and antiendomysium IgA antibodies
. All patients with positive antibody tests were offered upper gastrointest
inal endoscopy with distal duodenal biopsy. Thirteen patients (9.3%, 95% co
nfidence interval 5.0-15.4) had positive antigliadin and antiendomysium ant
ibodies, The prevalence of antibodies was 17% in women and 5.4% in men (8/4
7 vs. 5/93 respectively; relative risk 3.2, 95% confidence interval 1.1-9.1
). Distal duodenal biopsy performed in all but one of the patients showed m
ild villous atrophy with increased intraepithelial lymphocytes in three cas
es, subtotal villous atrophy in six, and total villous atrophy in three. Th
e prevalence of celiac disease in the patient group was significantly highe
r than that in the general population (P < .001) with a relative risk of 18
.6 (95% confidence interval 11.1-31.2). On the basis of the present finding
s, screening for celiac disease is an important tool in the initial diagnos
tic work-up of patients with chronic unexplained hypertransaminasemia.